7 Easy-to-Influence Survey Responses for Better Medicare Advantage Star Ratings
It’s too late to do anything about 2023 Medicare Star ratings. But it’s never too soon to influence what the next 1,000 random members surveyed will say about your plan.
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
Specialty Copay Programs – Accumulate, Maximize or Avoid?
Utilization of specialty medications continues to rise, and so do costs for patients and plan sponsors. Thanks to these rising costs, we see more plans choosing to implement copay adjustment programs, but it’s crucial to understand how they fit into your benefit and where they improve or hinder your plan.
Why Are the Most Important Rx Decision-makers Still in the Dark?
The only people who can write prescriptions typically have no idea what patients will pay at the pharmacy. It’s time to solve this problem.
Let’s Talk About Mental Health
Every May we raise awareness about mental health as we continue to help our members stay adherent by showing them affordable options for the medications they need.
Success With Point Benefit Solutions Hinges on the Pharmacy Factor
Many point benefits solutions have produced positive results for employers and health plans. However, their full potential depends on medication access and affordability.
Generic Dexilant® Joins the PPI Party, But Plenty of Alternatives Already Have
A widely prescribed acid reflux medication now has an authorized generic available. Good news, but five low-cost proton-pump inhibitor (PPIs) generics often work just as well.
Whatever the Numbers Say, Guess Who Keeps Paying More for Rx?
January produced another price hike party from drug makers. But some data indicate prescription prices are actually falling. For consumers? Same as it ever was, or worse.
On One Condition – Hypothyroidism
A collection of clinical insights from our team of in-house pharmacists. These industry veterans curate, …
A Little Joy Goes a Long Way
A $100 gift may not go as far as it once did, but the only inflation this holiday season was in the hearts of hundreds of RxSS employees and clients who gave their gifts to others.
On One Condition – High Cholesterol
One of our PharmDs talks about his journey with high cholesterol and shares 3 key trends he’s seeing with prescriptions to treat this chronic condition.
Stay COnnected
Share your email and once a month we’llsend you industry news and insights.
